LYEL
Lyell Immunopharma·NASDAQ
--
--(--)
--
--(--)
LYEL fundamentals
Lyell Immunopharma (LYEL) released its earnings on Aug 12, 2025: revenue was 8.00K (YoY -38.46%), beat estimates; EPS was -2.89 (YoY +19.72%), beat estimates.
Revenue / YoY
8.00K
-38.46%
EPS / YoY
-2.89
+19.72%
Report date
Aug 12, 2025
Earnings Call
4:00 PM on Aug 12, 2025
Meeting link.EPS
Actual | -29.4 | -3.5417 | -7 | -5.5371 | -1.9 | -5.6 | -0.6 | -3.6 | -5.2 | -4 | -4.2 | -4.7861 | -3.6 | -3.4 | -8.9 | -1.86 | -2.89 |
Forecast | -7.5 | -9.4 | -5.4087 | -5.55 | -4.383 | -6.2218 | -4.55 | -5.15 | -5.25 | -4.84 | -4.6 | -4.4 | -3.95 | -3.9 | -3.4 | -3.6 | -3.52 |
Surprise | -292.00% | +62.32% | -29.42% | +0.23% | +56.65% | +9.99% | +86.81% | +30.10% | +0.95% | +17.36% | +8.70% | -8.77% | +8.86% | +12.82% | -161.76% | +48.33% | +17.90% |
Revenue
Actual | 2.63M | 2.75M | 2.82M | 553.00K | 35.74M | 2.80M | 48.39M | 65.00K | 27.00K | 25.00K | 13.00K | 3.00K | 13.00K | 34.00K | 11.00K | 7.00K | 8.00K |
Forecast | 2.31M | 2.88M | 2.64M | 776.50K | 17.87M | 1.80M | 16.13M | -17.50K | 18.00K | 6.25K | 3.25K | 1.00K | 3.25K | 0 | 0 | 0 | 4.00K |
Surprise | +13.57% | -4.26% | +6.79% | -28.78% | +100.00% | +55.56% | +200.00% | +471.43% | +50.00% | +300.00% | +300.00% | +200.00% | +300.00% | 0.00% | 0.00% | 0.00% | +100.00% |
Earnings Call
You can ask Aime
What is Lyell Immunopharma's gross profit margin?What is the market's earnings forecast for Lyell Immunopharma next quarter?What is the revenue and EPS growth rate for Lyell Immunopharma year over year?What does Lyell Immunopharma do and what are its main business segments?What factors drove the changes in Lyell Immunopharma's revenue and profit?What guidance did Lyell Immunopharma's management provide for the next earnings period?What is Lyell Immunopharma's latest dividend and current dividend yield?Did Lyell Immunopharma beat or miss consensus estimates last quarter?
